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Abstract
Context: Lipotoxicity is a risk factor for developing obesity-related metabolic complications, including non-alcoholic fatty
liver disease, type 2 diabetes (DM2), cardiovascular disease and stroke. Yet, the mechanisms underlying the development of
lipotoxicity itself remain poorly understood. Here, we investigated whether glucose intolerance aggravates lipotoxicity by
evaluating the association between triglyceride (TG) concentrations and glucose tolerance status in a cross-sectional study
on obese Caucasian women at risk for DM2.
Methods: 913 obese females unknown to have diabetes were recruited (mean age: 41.26SD 12.3; median BMI: 36.2, IQR
32.9–40.2). Visceral (VAT) and subcutaneous abdominal adipose tissue volumes were quantified with computed
tomography. Glucose, insulin, and triglyceride concentrations were determined in fasting state and following a 75 gram
oral glucose tolerance test.
Results: Based on fasting and 2 h post-load glucose levels, 27% of the women had impaired glucose tolerance (IGT), and 8%
had newly diagnosed DM2. Fasting TG concentrations were similar between the IGT- and DM2-groups, and increased as
compared to women with normal glucose tolerance (NGT). Even when adjusting for age, hip circumference and VAT, fasting
TG concentrations remained elevated as compared to NGT. Mixed modelling analysis of post-load responses showed that
TG concentrations declined more slowly in the DM2-group as compared to IGT and NGT. However, when adjusting for VAT
the difference in decline between the glucose tolerance groups disappeared.
Conclusions: Glucose intolerance associates with elevated fasting TG concentrations in obese Caucasian women. We
propose that glucose intolerance and increased VAT reduce lipid disposal mechanisms and may accelerate lipotoxicity.
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Introduction
Lipotoxicity, or ectopic fat deposition of non-adipose tissue, may
contribute to the development of metabolic complications of
obesity, including type 2 diabetes (DM2), non-alcoholic fatty liver
disease, cardiovascular dysfunction, and stroke [1]. Ectopic lipid
deposition occurs when the lipid storage capacity of adipose tissue
is insufficient [2]. Because the liver, pancreas, skeletal- and cardiac
muscle, in which ectopic lipid deposition occurs, have a limited
capacity for storing lipids, cellular dysfunction and death may
occur in case of lipid overload [3,4].
Insight into mechanisms underlying the development of
lipotoxicity are rapidly evolving, but still incompletely understood
[5,6]. Although it seems reasonable to expect a systemic serum
component, multiple studies indicate that circulating levels of non-
esterified fatty acids (NEFA) are not directly related to the severity
of obesity and its complications [5]. Rather, serum triglyceride
(TG) concentrations might be critical for obesity-related metabolic
risk assessment [7]. For example, fasting TG concentrations are
importantly associated with body shape. Subjects with a large
waist circumference, which is associated with increased risk for
cardiovascular disease [8], have elevated TG concentrations,
whereas subjects with a large hip circumference, which is associated
with reduced risk [9,10], have reduced TG concentrations [7].
Accordingly, prospective studies in healthy young men could
ascribe a substantial proportion of risk for both DM2 and
cardiovascular disease to an increase in TG concentrations during
a five year follow-up [11,12].
Since glucose intolerance is importantly associated with an
elevated risk for DM2 and cardiovascular disease [13], we
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investigated whether the presence of glucose intolerance may
accelerate lipotoxicity in a cross-sectional study of a population at
increased risk for developing DM2, i.e. obese women. We
evaluated the association between glucose intolerance and fasting
TG concentrations, as well as with the course of alterations in TG
concentrations after an OGTT.
Methods
Setting and Participants
913 obese Caucasian females not known to have DM2 were
recruited from the outpatient clinic of the Department of
Diabetology, Metabolism, and Clinical Nutrition of the University
Hospital, Antwerp, Belgium. Patients consulted for problems with
their weight. Male patients were excluded as gender and/or sex
steroids affect TG [14]. Participants who were 18 years or older,
were included. Patients with very high fasting triglycerides
($7.7 mmol/L, Third Report of the National Cholesterol
Education Program [15], suspected thyroid disease (thyroid-
stimulating hormone ,0,1 mU/ml and free T4.18,8 pmol/L;
or thyroid-stimulating hormone .4 mU/ml and free
T4,9,8 pmol/L), manifestly elevated liver tests (more than 5 fold
the normal upper limits: aspartate transaminase .200 U/L,
alanine transaminase .280 U/L, alkaline phosphatase .485 U/
L, gamma-glutamyl transferase .145 U/L) and elevated high-
sensitivity C-reactive protein levels ($3.0 mg/dL may suggest the
presence of a major infection) were excluded. In addition, patients
using glucose or lipid-lowering medications and patients who had
undergone bariatric surgery were excluded. The study was
approved by the ethical committee of the Antwerp University
Hospital, and the study was performed according to the standards
on human experimentation in accordance with the Helsinki
Declaration of 1975 as revised in 1983 with written informed
consent of the participants.
Anthropometry and Imaging
All examinations were done in the morning between 8–10 h
a.m. after an overnight fast. Length, body weight and hip
circumference at the levels of the trochanter major were de-
termined in a standard medical examination. Computed tomog-
raphy at the L4–L5 level was carried out to measure the cross-
sectional areas of visceral abdominal adipose tissue (VAT) and
subcutaneous abdominal adipose tissue (SAT) according to the
technique described by Van der Kooy and Seidell et al. [16].
Laboratory Analyses
Venous blood samples were collected in the fasting state and
during the course of a glucose tolerance test at 30, 60, 90, 120, 150
and 180 minutes after the ingestion of 75 gram glucose. Plasma
glucose was measured with the glucose oxidase method (on Vitros
750 XRC; Ortho Clinical Diagnostics Inc, Rochester, NY).
Triglyceride levels were measured on Vitros 750XRC (Ortho
Clinical Diagnostics, Johnson & Johnson, Raritan, NJ). Insulin was
measured by a radioimmunoassay with the use of Pharmacia
Insulin RIA (Pharmacia Diagnostics, Uppsala, Sweden). Insulin
resistance was estimated using homeostasis model assessment
(HOMA-IR) as described by Matthews et al [17]. Glucose status
was determined according to the criteria of the American Diabetes
Association [18].
Statistical Analysis
Statistical calculations were carried out using IBM SPSS
statistics version 19 (SPSS Inc an IBM company, Chicago, IL).
Normal distribution of the data was verified with the Shapiro-Wilk
test and graphical methods (box plots and Q-Q plots). Variables
are presented as 6 standard deviation or in case of non-Gaussian
distribution as median (interquartile range). To show associations
with fasting TG Pearson’s correlation coefficients were presented.
If necessary in case of non-Gaussian distributed data, variables
were normalized by transformation into their natural logarithm
(Ln transformation). General linear modelling, which allows
adjustment for confounding, was deployed to evaluate potential
important determinants of fasting TG, including glucose tolerance
status. Finally, mixed modelling, with random intercept for
subjects to account for the dependency of the repeated measures,
was used to analyze the glucose, insulin and TG response following
glucose ingestion and to estimate fixed effects on the TG response
of different variables of interest, such as VAT, and age. A P-value
,0.05 was regarded as statistically significant.
Results
Ranking the participants based on their glucose tolerance status
resulted in 593 normal glucose tolerant (NGT) -subjects, 244
impaired glucose tolerant (IGT) -subjects, and 72 subjects with
newly diagnosed (DM2) (Table 1). Anthropometric and bio-
chemical data of the 3 groups are presented in Table 1. Age of the
NGT group was lower as compared to IGT and DM2. Body mass
index (BMI) was lower in NGT versus IGT, but similar between
IGT and DM2. VAT was lowest in NGT followed by IGT and
DM2. SAT and hip circumference did not differ among the three
groups. Fasting insulin levels and HOMA-IR were lowest in NGT
followed by IGT and DM2. Fasting TG, as well as 2 h post-load
insulin- and TG concentrations were similar between IGT and
DM2 and elevated as compared to NGT.
To identify additional determinants, apart from the glucose
tolerance status, of fasting TG concentrations, correlation
coefficients were calculated. The strongest correlate appeared to
be VAT, and then HOMA-IR (Table 2). Subsequently, multivar-
iate linear regression analysis confirmed the independent associ-
ation between fasting TG levels (dependent variable) and the
glucose tolerance status, after adjustment for VAT, hip circum-
ference and age (Table 3). Thus, independent of VAT, fasting TG
levels were lower in females with NGT as compared to IGT or
DM2.
To explore determinants of non-fasting TG concentrations, the
TG response after an 75 gram OGTT was analyzed using mixed
modelling. Figure 1 illustrates the alterations in glucose, insulin
and triglyceride concentrations during the course of the OGTT in
the three groups. As expected, the glucose curve differs according
to glucose tolerance status. Also, the insulin curve differs according
to glucose tolerance status. Specifically, the initial post-load
increase in insulin concentrations is faster and the duration more
limited in females with NGT, as compared to DM2, whereas the
insulin curve of females with IGT showed an intermediate
behaviour. Finally, the post-load TG concentrations showed on
average a decline in the various groups which seemed to be
reduced in females with DM2. Females with IGT showed a similar
post-load TG curve as females with NGT, although their initial
TG concentrations, as well as the post-load TG concentrations
were elevated as compared to females with NGT.
Subsequently, additional determinants of TG concentrations
after the OGTT were explored by mixed modelling analysis. This
analysis identified VAT as the most important determinant of
post-load TG concentrations. Accordingly, when distributing the
participants into tertiles of VAT an almost equivalent distribution
in post-load TG concentrations was observed among the three
Glucose Intolerance, VAT and Triglycerides
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groups (Figure 2). Furthermore, the initial difference between IGT
and DM2 lost statistical significance after adjustment for VAT.
Thus, fasting TG concentrations were lower in obese females
with NGT as compared to IGT or NDM. This effect is
independent of VAT. In contrast, the alterations in post-load
TG response among obese females with NGT, IGT or DM2 were
found to be dependent on the amount of VAT.
Discussion
The present study displays an important link between fasting
TG concentrations and glucose intolerance, as well as between the
course of alterations in TG concentrations after an OGTT and the
amount of VAT. These findings indicate that both glucose
intolerance and increased amounts of VAT promote elevations in
circulating TG concentrations, and thereby contribute to the
development of lipotoxicity.
A limitation of the present study is that a general accepted
systemic biomarker for lipotoxicity is not available. The use of
NEFA has been heavily criticized: as adipose tissue mass expands,
NEFA release per kilogram adipose tissue is downregulated, not
increased [5]. NEFA concentrations might be modulated by
altered function/expression of transporter proteins for fatty acids
[19]. Based on former studies [7,11,12], we therefore used
circulating TG levels as indicator for lipotoxicity. For non-fasting
TG concentrations, the course of TG alterations after an OGTT
was used instead of post-prandial TG levels after a standard mixed
meal, as performing both tests was practically not feasible in more
than 900 females. Another limitation is that results of the present
study are not applicable to men or to females of African origin, as
TG physiology is affected by sex steroids [14] and African descent
Table 1. Anthropometric and laboratory measurements of females subjects according to glucose tolerance status (n = 913).
NGT (n=593) IGT (n =244) DM2 (n=72) P PNGT-IGT PNGT-DM2 PIGT-DM2
Age (y) 38.74 (611.88) 44.94 (612.06) 48.14 (69.82) 0.001 ,0.001 ,0.001 0.106
Weight (kg) 98.3 (87.6–109.3) 100.9 (90.2–113.6) 104.0 (90.1–114.4) 0.006 0.017 0.077 0.883
Height (m) 1.66 (60.07) 1.65 (60.07) 1.62 (60.06) ,0.001 0.087 ,0.001 0.027
BMI (kg/m2) 35.6 (32.2–39.4) 36.9 (33.5–42.1) 39.0 (35.1–43.1) ,0.001 ,0.001 ,0.001 0.155
Hip circumference (cm) 120.0 (69.9) 119.4 (610.8) 119.0 (612.4) 0.595 – – –
VAT (cm2) 117.0 (90.3–162.0) 156.7 (121.0–213.0) 202.5 (149.5–283.8) ,0.001 ,0.001 ,0.001 0.001
SAT (cm2) 572.1 (6133.8) 574.7 (6123.5) 587.8 (6120.0) 0.646 – – –
Fasting plasma glucose (mmol/L) 4.5 (4.2–4.7) 4.7 (4.4–5.2) 5.8 (5.1–6.7) ,0.001 ,0.001 ,0.001 ,0.001
2 hour palsma glucose (mmol/L) 6.0 (5.2–6.7) 8.6 (8.1–9.4) 12.5 (11.5–14.3) ,0.001 ,0.001 ,0.001 ,0.001
Fasting plasma insulin (pmol/L) 93 (65–136) 121 (72–158) 158 (107–208) ,0.001 ,0.001 ,0.001 0.004
2 hour plasma insulin (pmol/L) 438 (265–782) 861 (488–1356) 753 (502–1435) ,0.001 ,0.001 ,0.001 0.998
HOMA-IR 2.5 (1.7–3.8) 3.5 (2.2–5.1) 5.8 (3.8–8.7) ,0.001 ,0.001 ,0.001 ,0.001
Fasting plasma TG (mmol/L) 1.3 (0.9–1.8) 1.6 (1.2–2.1) 1.6 (1.3–2.4) ,0.001 ,0.001 ,0.001 0.973
2 hour plasma TG (mmol/L) 1.1 (0.8–1.5) 1.3 (1.0–1.8) 1.3 (1.1–2.1) ,0.001 ,0.001 ,0.001 0.590
VAT, visceral abdominal adipose tissue; SAT, subcutaneous abdominal adipose tissue, HOMA-IR, homeostasis model assessment (calculated insulin resistance); NGT,
normal glucose tolerance; IGT, Impaired Glucose Tolerance; DM2, newly diagnosed type 2 diabetes.
Data are presented as mean (6SD) or median (25th percentile–75th percentile), in case of non-Gaussian distribution. Statistics according to ANOVA with Tukey correction
for multiple comparisons. P, P value for overall difference between women with NGT, IGT and DM2; PNGT-IGT, P-value for difference between women with NGT and
women with IGT; PNGT-DM2, P-value for difference between women with NGT and women with DM2; PIGT-DM2, P-value for differences between women with IGT and
women with DM2.
doi:10.1371/journal.pone.0045145.t001
Table 2. Pearson correlations coefficients (r) between fasting
serum triglycerides and potential determinants.
r P-value
Age 0.08 0.022
Weight a 0.13 ,0.001
Height 20.02 0.644
BMI a 0.14 ,0.001
Hip circumference 20.09 0.005
VAT a 0.28 ,0.001
SAT 0.03 0.478
Fasting plasma glucosea 0.15 ,0.001
2 hour plasma glucose a 0.26 ,0.001
Fasting plasma insulin a 0.21 ,0.001
2 hour plasma insulin a 0.20 ,0.001
Calculated insulin resistance (HOMA-IR)a 0.23 ,0.001
aIf appropriate, variables were transformed into their natural logarithm.
doi:10.1371/journal.pone.0045145.t002
Table 3. Results from general linear models with fasting
serum triglycerides as dependent variable.
Predictive variables in the model B SE P
Glucose tolerance status: ,0.001
IGT vs. NGT 0.125 0.0346 ,0.001
DM2 vs. NGT 0.079 0.0564 0.164
VAT 0.316 0.0377 ,0.001
Hip circumference 20.007 0.0015 ,0.001
Age 20.005 0.0014 ,0.001
If appropriate, variables were transformed into their natural logarithm.
doi:10.1371/journal.pone.0045145.t003
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[20]. Although a substantial number of females (n = 336) used oral
contraceptive pills or hormonal replacement therapy, we assume
that the sample size of this epidemiological study evens potential
individual effects on glucose- or lipid metabolism, as users are
randomly distributed. Finally, there was no power calculation with
a priori established primary end points, and the data are obtained
in a cross-sectional study, because a prospective evaluation of
patients with glucose intolerance or DM2 without treatment cannot
be regarded as ethical. Despite these limitations, the present study
provides arguments – for the first time based on a large population
at risk – that a reduced capacity to dispose serum TG is the most
likely explanation for the well known association between ‘‘the
hypertriglyceridemic waist (estimate of amount of visceral adipose
tissue)’’ and ‘‘high risk of CHD’’ in glucose intolerance and DM2
[8]. I.e. lipotoxicity is confirmed to be a main issue for CHD [21],
and is related to glucose intolerance and VAT.
Changes in visceral fat of Japanese men have been associated
with incident metabolic syndrome, such that investigators
concluded that, for prevention, a lifestyle should be adopted that
does not increase visceral fat [22]. The same study showed also
a positive association between changes in visceral fat and changes
in fasting TG concentrations, confirming that visceral adipose
tissue and TG are strongly related. The waist circumference has
not only been associated with metabolic syndrome, DM2 and
cardiovascular disease [8], but also with liver fibrosis in children
[23]. The present findings confirm the notion of the importance of
body shape for lipotoxicity and obesity-related metabolic compli-
cations [2,7], and extent our knowledge by demonstrating that the
amount of VAT is also a predominant regulator of non-fasting TG
levels in obese females with or without a disturbed glucose
metabolism. A dynamic study showed similar findings in detail in
a limited number of obese males; they concluded that subjects with
increased adiposity fails to appropriately upregulate meal fat-
storage. This sign of maladaptation was thereafter suggested as the
potential pathophysiologic basis of ectopic fat deposition in obesity
[24].
Glucose intolerance in obese subjects has been associated with
metabolically ‘‘inflexible’’ high basal intramuscular triglyceride
concentrations [25], confirming the relationship between glucose
intolerance and lipotoxicity. The deregulation of intramyocellular
fatty acid metabolism appears to be one of the initial features of
insulin resistance of the skeletal muscle, closely linked to a reduced
capacity to dispose lipids properly [2,26].
Collectively, the results of the present study provide a meaning-
ful direction for future research into obesity-related metabolic
complications. I.e. new studies should aim to reveal the relation-
ship between, on the one hand, the capacity to dispose serum
lipids, and, on the other hand, glucose intolerance and the amount
of visceral adipose tissue. Important questions that remain to be
addressed include the mechanism underlying the positive associ-
ation between TG concentrations and the amount of VAT, as well
as the understanding of the association between elevated fasting
Figure 1. The post-load course of glucose-, insulin- and
triglyceride alterations during 3 h after an oral glucose
tolerance test (75 g) in obese females with normal glucose
tolerance (NGT, open circles), pre-diabetes (IGT, gray circles)
and newly diagnosed type 2 diabetes (DM2, black circles).
Glucose, see panel A; insulin, see panel B; triglycerides, see panel C.
***Statistical differences in the post-load course after an 75 g OGTT
between NGT, IGT and DM2. **Statistical differences in the post-load
course after an 75 g OGTT between IGT and DM2. See Information S1.
doi:10.1371/journal.pone.0045145.g001
Figure 2. The post-load course of triglyceride alterations
during 3 h after an 75 g OGTT in obese females are statistically
different (***) according to tertiles of visceral adipose tissue
(3rd tertile: females with largest amount of visceral adipose
tissue). See supporting information S1.
doi:10.1371/journal.pone.0045145.g002
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TG concentrations and visceral adipocyte size [6]? Finally, it
remains to be established to what extent alterations in adipokine
secretion from enlarged VAT contribute to the reduced capacity
to dispose serum lipids [27].
In conclusion, fasting TG concentrations are associated with
impaired glucose tolerance in obese Caucasian females, and the
course of alterations in TG concentrations after an OGTT is
determined by the amount of VAT. The findings suggest that
glucose intolerance and the amount of VAT interfere with
disposing of serum lipids.
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